12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several healthcare stocks experienced significant movements. Exicure (XCUR) saw a 29.8% increase, while Telesis Bio (TBIO) rose by 21.88%. Jin Medical International (ZJYL) increased by 21.33%, Estrella Immunopharma (ESLA) by 15.78%, Amarin Corp (AMRN) by 15.35%, and Bio-Path Hldgs (BPTH) by 12.99%. Conversely, Aclaris Therapeutics (ACRS) fell by 14.1%, Forian (FORA) by 9.93%, Veradigm (MDRX) by 9.86%, cbdMD (YCBD) by 8.87%, ThermoGenesis Holdings (THMO) by 8.58%, and Qilian Intl Hldg Gr (QLI) by 8.32%.
January 10, 2024 | 1:05 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aclaris Therapeutics' shares fell by 14.1% to $1.1, with a market cap of $77.9 million.
The significant pre-market decline in Aclaris Therapeutics' shares could indicate negative sentiment, potentially leading to a short-term downtrend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Forian's stock decreased by 9.93% to $2.54, with a market cap of $78.6 million.
The pre-market drop in Forian's stock price may reflect investor concerns, potentially leading to a short-term negative trend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Veradigm's stock decreased by 9.86% to $9.7, with a market cap of $1.0 billion.
The notable pre-market decline in Veradigm's stock could suggest a bearish sentiment, possibly affecting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Qilian Intl Hldg Gr's shares declined by 8.32% to $0.58, with a market cap of $20.6 million.
The pre-market decline for Qilian Intl Hldg Gr indicates potential investor caution, which may lead to a short-term decrease in stock price.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
ThermoGenesis Holdings' stock decreased by 8.58% to $0.46, with a market cap of $1.4 million.
The drop in ThermoGenesis Holdings' stock in pre-market trading could signal a bearish trend, possibly affecting its short-term price.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
cbdMD's stock decreased by 8.87% to $0.85, with a market cap of $2.5 million.
The pre-market decrease in cbdMD's stock price may lead to negative investor sentiment and a possible short-term downtrend.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Amarin Corp's shares increased by 15.35% to $1.12, with a market cap of $457.2 million.
Amarin Corp's notable pre-market increase may attract more investors, potentially leading to a short-term uptrend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Bio-Path Hldgs' shares rose by 12.99% to $0.6, with a market cap of $7.3 million.
The double-digit percentage increase in Bio-Path Hldgs' stock suggests a positive short-term outlook, potentially leading to further gains.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Estrella Immunopharma's stock increased by 15.78% to $1.1, with a market cap of $38.7 million.
The pre-market rise in Estrella Immunopharma's stock price could indicate a short-term bullish trend for the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Telesis Bio's shares increased by 21.88% to $0.46, with a market cap of $13.6 million.
The sharp rise in Telesis Bio's shares indicates a bullish outlook that could persist in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Exicure's stock rose by 29.8% to $0.8, with a market cap of $6.9 million.
The significant pre-market increase in Exicure's stock price suggests positive investor sentiment, which could lead to a short-term upward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Jin Medical International shares rose by 21.33% to $110.0, with a market cap of $852.5 million.
The substantial pre-market gain for Jin Medical International may lead to continued investor interest and a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100